CNV2197944

DRUG2 trials

Sponsors

Convergence Pharmaceuticals

Conditions

Diabetic Peripheral NeuropathyPost-herpetic Neuralgia

Phase 2

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia

CompletedNCT01848730

Convergence PharmaceuticalsPost-herpetic Neuralgia

Start: 2013-04-30End: 2014-05-31Updated: 2014-10-30

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy

CompletedNCT01893125

Convergence PharmaceuticalsDiabetic Peripheral Neuropathy

Start: 2013-08-31End: 2014-09-30Updated: 2014-10-30